Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB)
CUSIP: 207523101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.000174 per share
- Shares outstanding
- 62,779,302
- Total 13F shares
- 2,976,236
- Share change
- -970,923
- Total reported value
- $4,523,173
- Price per share
- $1.52
- Number of holders
- 12
- Value change
- -$1,478,482
- Number of buys
- 3
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 207523101:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
|
Company |
3.3%
|
2,061,338
|
$3,586,728 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.7%
|
1,040,067
|
$1,809,717 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.81%
|
510,701
|
$888,620 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.38%
|
239,900
|
$417,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,961
|
$48,652 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
20,000
|
$35,000 | — | 31 Mar 2024 | |
| Keudell/Morrison Wealth Management |
13F
|
Company |
0.03%
|
19,700
|
$34,278 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
16,520
|
$28,744 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
10,805
|
$18,801 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$211 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
46
|
$80 | — | 31 Mar 2024 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.